DEVELOPMENT OF STEREOSELECTIVE AND ENANTIOSELECTIVE SYNTHESIS METHODS: FROM CLASSICAL APPROACHES TO MODERN CATALYTIC SYSTEMS
DOI:
https://doi.org/10.55640/Keywords:
stereoselectivity, enantioselectivity, asymmetric catalysis, chiral synthesis, organocatalysis, biocatalysis, enantiomeric excess, pharmaceutical chemistry.Abstract
This article presents a comprehensive analysis of the development and advancement of stereoselective and enantioselective synthesis methods in organic chemistry. Stereocontrol in chemical synthesis has emerged as one of the most significant achievements in modern chemistry, enabling the preparation of enantiomerically pure compounds essential for pharmaceuticals, agrochemicals, and advanced materials. The study examines the evolution from classical resolution techniques to contemporary asymmetric catalysis, including asymmetric hydrogenation, epoxidation, dihydroxylation, and organocatalytic transformations. Historical development is traced from early stereochemical concepts through Nobel Prize-winning catalytic methods to current state-of-the-art approaches. Experimental evaluation of representative stereoselective reactions demonstrates the superiority of catalytic asymmetric methods over classical approaches, achieving enantiomeric excesses exceeding 99% with catalyst loadings as low as 0.01-1 mol%. The discussion emphasizes mechanistic understanding, catalyst design principles, and industrial applications. Results show that asymmetric catalysis has revolutionized pharmaceutical synthesis, with over 50% of marketed drugs requiring enantiopure intermediates. Modern organocatalysis and biocatalysis represent sustainable alternatives to traditional metal catalysis, achieving comparable selectivity with improved environmental profiles.
Downloads
References
1. Bentley R. Role of sulfur chirality in the chemical processes of biology // Chemical Society Reviews. 2005. Vol. 34(7). P. 609-624. DOI: 10.1039/b418284g
2. Kim J.H., Scialli A.R. Thalidomide: the tragedy of birth defects and the effective treatment of disease // Toxicological Sciences. 2011. Vol. 122(1). P. 1-6. DOI: 10.1093/toxsci/kfr088
3. Christmann M., Bräse S. Asymmetric Synthesis: The Essentials. 2nd ed. Weinheim: Wiley-VCH, 2007. 324 p.
4. Noyori R. Asymmetric catalysis: science and opportunities (Nobel Lecture) // Angewandte Chemie International Edition. 2002. Vol. 41(12). P. 2008-2022. DOI: 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4
5. Jacobsen E.N., Pfaltz A., Yamamoto H. Comprehensive Asymmetric Catalysis. Heidelberg: Springer, 1999. 1500 p.
6. Walsh P.J., Kozlowski M.C. Fundamentals of Asymmetric Catalysis. Sausalito: University Science Books, 2009. 850 p.
7. Caner H., Groner E., Levy L., Agranat I. Trends in the development of chiral drugs // Drug Discovery Today. 2004. Vol. 9(3). P. 105-110. DOI: 10.1016/S1359-6446(03)02904-0
8. Beletskaya I.P., Nájera C., Yus M. Stereodivergent catalysis // Chemical Reviews. 2018. Vol. 118(10). P. 5080-5200. DOI: 10.1021/acs.chemrev.7b00511
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

